ReP USP - Resultado da busca

Artigo de periodico
Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT (2023)
Gurnari, Carmelo; Robin, Marie; Godley, Lucy A.; Onida, Francesco; Ciceri, Fabio; Bonfim, Carmem; Makishima, Hideki; Hamad, Nada; Voso, Maria Teresa; Mecucci, Cristina; Duarte, Fernando Barroso; Sebert, Marie; Calado, Rodrigo Tocantins
Source: The Lancet Haematology. Unidade: FMRP
Subjects: PREDISPOSIÇÃO GENÉTICA PARA DOENÇA, DOENÇA ENXERTO-HOSPEDEIRO, CÉLULAS-TRONCO, NEOPLASIAS, TRANSPLANTE HOMÓLOGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GURNARI, Carmelo et al. Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT. The Lancet Haematology, v. 10, n. 12, p. e994-e1005, 2023Tradução . . Disponível em: https://doi.org/10.1016/S2352-3026(23)00265-X. Acesso em: 03 nov. 2024.
APA
Gurnari, C., Robin, M., Godley, L. A., Onida, F., Ciceri, F., Bonfim, C., et al. (2023). Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT. The Lancet Haematology, 10( 12), e994-e1005. doi:10.1016/S2352-3026(23)00265-X
NLM
Gurnari C, Robin M, Godley LA, Onida F, Ciceri F, Bonfim C, Makishima H, Hamad N, Voso MT, Mecucci C, Duarte FB, Sebert M, Calado RT. Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT [Internet]. The Lancet Haematology. 2023 ; 10( 12): e994-e1005.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/S2352-3026(23)00265-X
Vancouver
Gurnari C, Robin M, Godley LA, Onida F, Ciceri F, Bonfim C, Makishima H, Hamad N, Voso MT, Mecucci C, Duarte FB, Sebert M, Calado RT. Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT [Internet]. The Lancet Haematology. 2023 ; 10( 12): e994-e1005.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/S2352-3026(23)00265-X
Artigo de periodico
VI‐RADS for bladder cancer: current applications and future developments (2022)
Panebianco, Valeria; Pecoraro, Martina; Del Giudice, Francesco; Takeuchi, Mitsuru; Muglia, Valdair Francisco ; Messina, Emanuele; Cipollari, Stefano; Giannarini, Gianluca; Catalano, Carlo; Narumi, Yoshifumi
Source: Journal of Magnetic Resonance Imaging. Unidade: FMRP
Subjects: NEOPLASIAS DA BEXIGA, IMAGEM POR RESSONÂNCIA MAGNÉTICA, PROTOCOLOS CLÍNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PANEBIANCO, Valeria et al. VI‐RADS for bladder cancer: current applications and future developments. Journal of Magnetic Resonance Imaging, v. 55, n. 1, p. 23-36, 2022Tradução . . Disponível em: https://doi.org/10.1002/jmri.27361. Acesso em: 03 nov. 2024.
APA
Panebianco, V., Pecoraro, M., Del Giudice, F., Takeuchi, M., Muglia, V. F., Messina, E., et al. (2022). VI‐RADS for bladder cancer: current applications and future developments. Journal of Magnetic Resonance Imaging, 55( 1), 23-36. doi:10.1002/jmri.27361
NLM
Panebianco V, Pecoraro M, Del Giudice F, Takeuchi M, Muglia VF, Messina E, Cipollari S, Giannarini G, Catalano C, Narumi Y. VI‐RADS for bladder cancer: current applications and future developments [Internet]. Journal of Magnetic Resonance Imaging. 2022 ; 55( 1): 23-36.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1002/jmri.27361
Vancouver
Panebianco V, Pecoraro M, Del Giudice F, Takeuchi M, Muglia VF, Messina E, Cipollari S, Giannarini G, Catalano C, Narumi Y. VI‐RADS for bladder cancer: current applications and future developments [Internet]. Journal of Magnetic Resonance Imaging. 2022 ; 55( 1): 23-36.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1002/jmri.27361
Artigo de periodico
The combination of gefitinib with ATRA and ATO induces myeloid differentiation in acute promyelocytic leukemia resistant cells (2021)
Almeida, Luciana Yamamoto de; Martins, Diego A. Pereira; Weinhäuser, Isabel; Ortiz, César; Cândido, Larissa A.; Lange, Ana Paula; Abreu, Nayara F. de; Mendonza, Sílvia E. S.; Wagatsuma, Virgínia M. de Deus; Nascimento, Mariane C. do; Paiva, Helder H.; Alves-Paiva, Raquel M.; Bonaldo, Camila C. O. M.; Nascimento, Daniele C.; Alves-Filho, José Carlos; Scheucher, Priscila S.; Lima, Ana Silvia Gouvêa de; Schuringa, Jan Jacob; Ammantuna, Emanuele; Ottone, Tiziana; Noguera, Nelida I.; Araujo, Cleide L.; Rego, Eduardo M.
Source: Frontiers in Oncology. Unidades: FMRP, FM
Subjects: LEUCEMIA, CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Luciana Yamamoto de et al. The combination of gefitinib with ATRA and ATO induces myeloid differentiation in acute promyelocytic leukemia resistant cells. Frontiers in Oncology, v. 11, 2021Tradução . . Disponível em: https://doi.org/10.3389/fonc.2021.686445. Acesso em: 03 nov. 2024.
APA
Almeida, L. Y. de, Martins, D. A. P., Weinhäuser, I., Ortiz, C., Cândido, L. A., Lange, A. P., et al. (2021). The combination of gefitinib with ATRA and ATO induces myeloid differentiation in acute promyelocytic leukemia resistant cells. Frontiers in Oncology, 11. doi:10.3389/fonc.2021.686445
NLM
Almeida LY de, Martins DAP, Weinhäuser I, Ortiz C, Cândido LA, Lange AP, Abreu NF de, Mendonza SES, Wagatsuma VM de D, Nascimento MC do, Paiva HH, Alves-Paiva RM, Bonaldo CCOM, Nascimento DC, Alves-Filho JC, Scheucher PS, Lima ASG de, Schuringa JJ, Ammantuna E, Ottone T, Noguera NI, Araujo CL, Rego EM. The combination of gefitinib with ATRA and ATO induces myeloid differentiation in acute promyelocytic leukemia resistant cells [Internet]. Frontiers in Oncology. 2021 ; 11[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fonc.2021.686445
Vancouver
Almeida LY de, Martins DAP, Weinhäuser I, Ortiz C, Cândido LA, Lange AP, Abreu NF de, Mendonza SES, Wagatsuma VM de D, Nascimento MC do, Paiva HH, Alves-Paiva RM, Bonaldo CCOM, Nascimento DC, Alves-Filho JC, Scheucher PS, Lima ASG de, Schuringa JJ, Ammantuna E, Ottone T, Noguera NI, Araujo CL, Rego EM. The combination of gefitinib with ATRA and ATO induces myeloid differentiation in acute promyelocytic leukemia resistant cells [Internet]. Frontiers in Oncology. 2021 ; 11[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fonc.2021.686445
Artigo de periodico-carta/editorial
Efficacy matters [Carta]: broadening complement inhibition in COVID-19 (2021)
Mastellos, Dimitrios C.; Skendros, Panagiotis; Calado, Rodrigo Tocantins ; Risitano, Antonio M.; Lambris, John D.
Source: The Lancet Rheumatology. Unidade: FMRP
Subjects: ENSAIO CLÍNICO CONTROLADO RANDOMIZADO, COVID-19, NEUTRÓFILOS, COAGULAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MASTELLOS, Dimitrios C. et al. Efficacy matters [Carta]: broadening complement inhibition in COVID-19. The Lancet Rheumatology. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S2665-9913(20)30423-9. Acesso em: 03 nov. 2024. , 2021
APA
Mastellos, D. C., Skendros, P., Calado, R. T., Risitano, A. M., & Lambris, J. D. (2021). Efficacy matters [Carta]: broadening complement inhibition in COVID-19. The Lancet Rheumatology. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/S2665-9913(20)30423-9
NLM
Mastellos DC, Skendros P, Calado RT, Risitano AM, Lambris JD. Efficacy matters [Carta]: broadening complement inhibition in COVID-19 [Internet]. The Lancet Rheumatology. 2021 ; 3( 2): e95.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/S2665-9913(20)30423-9
Vancouver
Mastellos DC, Skendros P, Calado RT, Risitano AM, Lambris JD. Efficacy matters [Carta]: broadening complement inhibition in COVID-19 [Internet]. The Lancet Rheumatology. 2021 ; 3( 2): e95.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/S2665-9913(20)30423-9
Artigo de periodico
Use of chest imaging in the diagnosis and management of COVID-19: a WHO rapid advice guide (2021)
Akl, Elie A.; Blažić, Ivana; Frija, Guy; Chou, Roger; Appiah, John Adabie; Fatehi, Mansoor; Flor, Nicola; Jafri, Hussain; Jin, Zheng-Yu; Kauczor, Hans Ulrich; Muglia, Valdair Francisco ; Sanchez, Marcelo
Source: Radiology. Unidade: FMRP
Subjects: COVID-19, PULMÃO, DIAGNÓSTICO POR IMAGEM, TOMOGRAFIA, ULTRASSONOGRAFIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AKL, Elie A. et al. Use of chest imaging in the diagnosis and management of COVID-19: a WHO rapid advice guide. Radiology, v. 298, n. 2, p. E63-E69, 2021Tradução . . Disponível em: https://doi.org/10.1148/radiol.2020203173. Acesso em: 03 nov. 2024.
APA
Akl, E. A., Blažić, I., Frija, G., Chou, R., Appiah, J. A., Fatehi, M., et al. (2021). Use of chest imaging in the diagnosis and management of COVID-19: a WHO rapid advice guide. Radiology, 298( 2), E63-E69. doi:10.1148/radiol.2020203173
NLM
Akl EA, Blažić I, Frija G, Chou R, Appiah JA, Fatehi M, Flor N, Jafri H, Jin Z-Y, Kauczor HU, Muglia VF, Sanchez M. Use of chest imaging in the diagnosis and management of COVID-19: a WHO rapid advice guide [Internet]. Radiology. 2021 ; 298( 2): E63-E69.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1148/radiol.2020203173
Vancouver
Akl EA, Blažić I, Frija G, Chou R, Appiah JA, Fatehi M, Flor N, Jafri H, Jin Z-Y, Kauczor HU, Muglia VF, Sanchez M. Use of chest imaging in the diagnosis and management of COVID-19: a WHO rapid advice guide [Internet]. Radiology. 2021 ; 298( 2): E63-E69.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1148/radiol.2020203173
Artigo de periodico
NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia (2020)
Thomé, Carolina Hassibe ; Ferreira, Germano Aguiar ; Martins, Diego Antonio Pereira ; Santos, Guilherme Augusto dos; Ortiz, César Alexander; Souza, Lucas Eduardo Botelho de ; Sobral, Lays Martins; Silva, Cleide Lúcia Araújo; Scheucher, Priscila Santos ; Gil, Cristiane Damas; Leopoldino, Andréia Machado ; Silveira, Douglas Rafaele Almeida ; Silva, Juan Luiz Coelho da ; Traina, Fabiola ; Koury, Luisa C.; Melo, Raul A. M.; Bittencourt, Rosane; Pagnano, Katia; Pasquini, Ricardo; Nunes, Elenaide C.; Fagundes, Evandro M.; Gloria, Ana Beatriz F.; kerbauy, Fábio Rodrigues; Chauffaille, Maria de Lourdes; Keating, Armand; Tallman, Martin S.; Ribeiro, Raul C.; Dillon, Richard; Ganser, Arnold; Löwenberg, Bob; Valk, Peter; Lo-Coco, Francesco; Sanz, Miguel A.; Berliner, Nancy; Faça, Vitor Marcel ; Rego, Eduardo Magalhaes
Source: Scientific Reports. Unidades: FMRP, FCFRP, FM
Subjects: PROTEÍNAS, TRANSDUÇÃO DE SINAL CELULAR, QUIMIOTERAPIA, ANTINEOPLÁSICOS, MEDULA ÓSSEA, DIFERENCIAÇÃO CELULAR, SOBREVIVÊNCIA CELULAR, LEUCEMIA, FARMACOTERAPIA, ANÁLISE DE SOBREVIVÊNCIA, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
THOMÉ, Carolina Hassibe et al. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia. Scientific Reports, v. 10, n. 1, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41598-020-66223-2. Acesso em: 03 nov. 2024.
APA
Thomé, C. H., Ferreira, G. A., Martins, D. A. P., Santos, G. A. dos, Ortiz, C. A., Souza, L. E. B. de, et al. (2020). NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia. Scientific Reports, 10( 1). doi:10.1038/s41598-020-66223-2
NLM
Thomé CH, Ferreira GA, Martins DAP, Santos GA dos, Ortiz CA, Souza LEB de, Sobral LM, Silva CLA, Scheucher PS, Gil CD, Leopoldino AM, Silveira DRA, Silva JLC da, Traina F, Koury LC, Melo RAM, Bittencourt R, Pagnano K, Pasquini R, Nunes EC, Fagundes EM, Gloria ABF, kerbauy FR, Chauffaille M de L, Keating A, Tallman MS, Ribeiro RC, Dillon R, Ganser A, Löwenberg B, Valk P, Lo-Coco F, Sanz MA, Berliner N, Faça VM, Rego EM. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia [Internet]. Scientific Reports. 2020 ; 10( 1):[citado 2024 nov. 03 ] Available from: https://doi.org/10.1038/s41598-020-66223-2
Vancouver
Thomé CH, Ferreira GA, Martins DAP, Santos GA dos, Ortiz CA, Souza LEB de, Sobral LM, Silva CLA, Scheucher PS, Gil CD, Leopoldino AM, Silveira DRA, Silva JLC da, Traina F, Koury LC, Melo RAM, Bittencourt R, Pagnano K, Pasquini R, Nunes EC, Fagundes EM, Gloria ABF, kerbauy FR, Chauffaille M de L, Keating A, Tallman MS, Ribeiro RC, Dillon R, Ganser A, Löwenberg B, Valk P, Lo-Coco F, Sanz MA, Berliner N, Faça VM, Rego EM. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia [Internet]. Scientific Reports. 2020 ; 10( 1):[citado 2024 nov. 03 ] Available from: https://doi.org/10.1038/s41598-020-66223-2
Artigo de periodico
Overview of VI-RADS in bladder cancer (2020)
Pecoraro, Martina; Takeuchi, Mitsuru; Vargas, Hebert A.; Muglia, Valdair Francisco; Cipollari, Stefano; Catalano, Carlo; Panebianco, Valeria
Source: American Journal of Roentgenology. Unidade: FMRP
Subjects: IMAGEM POR RESSONÂNCIA MAGNÉTICA, ESTADIAMENTO DE NEOPLASIAS, NEOPLASIAS DA BEXIGA, DIAGNÓSTICO POR IMAGEM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PECORARO, Martina et al. Overview of VI-RADS in bladder cancer. American Journal of Roentgenology, v. 214, n. 6, p. 1259-1268, 2020Tradução . . Disponível em: https://doi.org/10.2214/AJR.20.22763. Acesso em: 03 nov. 2024.
APA
Pecoraro, M., Takeuchi, M., Vargas, H. A., Muglia, V. F., Cipollari, S., Catalano, C., & Panebianco, V. (2020). Overview of VI-RADS in bladder cancer. American Journal of Roentgenology, 214( 6), 1259-1268. doi:10.2214/AJR.20.22763
NLM
Pecoraro M, Takeuchi M, Vargas HA, Muglia VF, Cipollari S, Catalano C, Panebianco V. Overview of VI-RADS in bladder cancer [Internet]. American Journal of Roentgenology. 2020 ; 214( 6): 1259-1268.[citado 2024 nov. 03 ] Available from: https://doi.org/10.2214/AJR.20.22763
Vancouver
Pecoraro M, Takeuchi M, Vargas HA, Muglia VF, Cipollari S, Catalano C, Panebianco V. Overview of VI-RADS in bladder cancer [Internet]. American Journal of Roentgenology. 2020 ; 214( 6): 1259-1268.[citado 2024 nov. 03 ] Available from: https://doi.org/10.2214/AJR.20.22763
Artigo de periodico
Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy (2020)
Mastellos, Dimitrios C.; Silva, Bruno Garcia Peixoto Pires da; Fonseca, Benedito Antonio Lopes da; Fonseca, Natasha Peixoto; Martins, Maria Auxiliadora; Mastaglio, Sara; Ruggeri, Annalisa; Sironi, Marina; Radermacher, Peter; Chrysanthopoulou, Akrivi; Skendros, Panagiotis; Ritis, Konstantinos; Manfra, Ilenia; Iacobelli, Simona; Huber-Lang, Markus; Nilsson, Bo; Yancopoulou, Despina; Connolly, E. Sander; Garlanda, Cecilia; Ciceri, Fabio; Risitano, Antonio M.; Calado, Rodrigo Tocantins; Lambris, John D.
Source: Clinical Immunology. Unidade: FMRP
Subjects: COVID-19, TROMBOSE, FÁRMACOS, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MASTELLOS, Dimitrios C. et al. Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy. Clinical Immunology, v. 220, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.clim.2020.108598. Acesso em: 03 nov. 2024.
APA
Mastellos, D. C., Silva, B. G. P. P. da, Fonseca, B. A. L. da, Fonseca, N. P., Martins, M. A., Mastaglio, S., et al. (2020). Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy. Clinical Immunology, 220. doi:10.1016/j.clim.2020.108598
NLM
Mastellos DC, Silva BGPP da, Fonseca BAL da, Fonseca NP, Martins MA, Mastaglio S, Ruggeri A, Sironi M, Radermacher P, Chrysanthopoulou A, Skendros P, Ritis K, Manfra I, Iacobelli S, Huber-Lang M, Nilsson B, Yancopoulou D, Connolly ES, Garlanda C, Ciceri F, Risitano AM, Calado RT, Lambris JD. Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy [Internet]. Clinical Immunology. 2020 ; 220[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.clim.2020.108598
Vancouver
Mastellos DC, Silva BGPP da, Fonseca BAL da, Fonseca NP, Martins MA, Mastaglio S, Ruggeri A, Sironi M, Radermacher P, Chrysanthopoulou A, Skendros P, Ritis K, Manfra I, Iacobelli S, Huber-Lang M, Nilsson B, Yancopoulou D, Connolly ES, Garlanda C, Ciceri F, Risitano AM, Calado RT, Lambris JD. Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy [Internet]. Clinical Immunology. 2020 ; 220[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.clim.2020.108598
Artigo de periodico
Diagnostic performance of vesical imaging reporting and data system for the prediction of muscle-invasive bladder cancer: a systematic review and meta-analysis (2020)
Woo, Sungmin; Panebianco, Valeria; Narumi, Yoshifumi; Del Giudice, Francesco; Muglia, Valdair Francisco ; Takeuchi, Mitsuru; Ghafoor, Soleen; Bochner, Bernard H.; Goh, Alvin C.; Hricak, Hedvig; Catto, James W. F.; Vargas, Hebert Alberto
Source: European Urology Oncology. Unidade: FMRP
Subjects: NEOPLASIAS DA BEXIGA, DIAGNÓSTICO, DIAGNÓSTICO POR IMAGEM, RESSONÂNCIA MAGNÉTICA, ESTADIAMENTO DE NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WOO, Sungmin et al. Diagnostic performance of vesical imaging reporting and data system for the prediction of muscle-invasive bladder cancer: a systematic review and meta-analysis. European Urology Oncology, v. 3, n. 3, p. 306-315, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.euo.2020.02.007. Acesso em: 03 nov. 2024.
APA
Woo, S., Panebianco, V., Narumi, Y., Del Giudice, F., Muglia, V. F., Takeuchi, M., et al. (2020). Diagnostic performance of vesical imaging reporting and data system for the prediction of muscle-invasive bladder cancer: a systematic review and meta-analysis. European Urology Oncology, 3( 3), 306-315. doi:10.1016/j.euo.2020.02.007
NLM
Woo S, Panebianco V, Narumi Y, Del Giudice F, Muglia VF, Takeuchi M, Ghafoor S, Bochner BH, Goh AC, Hricak H, Catto JWF, Vargas HA. Diagnostic performance of vesical imaging reporting and data system for the prediction of muscle-invasive bladder cancer: a systematic review and meta-analysis [Internet]. European Urology Oncology. 2020 ; 3( 3): 306-315.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.euo.2020.02.007
Vancouver
Woo S, Panebianco V, Narumi Y, Del Giudice F, Muglia VF, Takeuchi M, Ghafoor S, Bochner BH, Goh AC, Hricak H, Catto JWF, Vargas HA. Diagnostic performance of vesical imaging reporting and data system for the prediction of muscle-invasive bladder cancer: a systematic review and meta-analysis [Internet]. European Urology Oncology. 2020 ; 3( 3): 306-315.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.euo.2020.02.007
Artigo de periodico
Semi-quantitative grading and extended semi-quantitative grading for osteoporotic vertebral deformity: a radiographic image database for education and calibration (2020)
Wáng, Yì Xiáng J.; Diacinti, Daniele; Yu, Wei; Cheng, Xiao-Guang; Nogueira-Barbosa, Marcello Henrique ; Che-Nordin, Nazmi; Guglielmi, Giuseppe; Ruiz Santiago, Fernando
Source: Annals of Translational Medicine. Unidade: FMRP
Subjects: OSTEOPOROSE, COLUNA VERTEBRAL, FRATURAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WÁNG, Yì Xiáng J. et al. Semi-quantitative grading and extended semi-quantitative grading for osteoporotic vertebral deformity: a radiographic image database for education and calibration. Annals of Translational Medicine, v. 8, n. 6, 2020Tradução . . Disponível em: https://doi.org/10.21037/atm.2020.02.23. Acesso em: 03 nov. 2024.
APA
Wáng, Y. X. J., Diacinti, D., Yu, W., Cheng, X. -G., Nogueira-Barbosa, M. H., Che-Nordin, N., et al. (2020). Semi-quantitative grading and extended semi-quantitative grading for osteoporotic vertebral deformity: a radiographic image database for education and calibration. Annals of Translational Medicine, 8( 6). doi:10.21037/atm.2020.02.23
NLM
Wáng YXJ, Diacinti D, Yu W, Cheng X-G, Nogueira-Barbosa MH, Che-Nordin N, Guglielmi G, Ruiz Santiago F. Semi-quantitative grading and extended semi-quantitative grading for osteoporotic vertebral deformity: a radiographic image database for education and calibration [Internet]. Annals of Translational Medicine. 2020 ; 8( 6):[citado 2024 nov. 03 ] Available from: https://doi.org/10.21037/atm.2020.02.23
Vancouver
Wáng YXJ, Diacinti D, Yu W, Cheng X-G, Nogueira-Barbosa MH, Che-Nordin N, Guglielmi G, Ruiz Santiago F. Semi-quantitative grading and extended semi-quantitative grading for osteoporotic vertebral deformity: a radiographic image database for education and calibration [Internet]. Annals of Translational Medicine. 2020 ; 8( 6):[citado 2024 nov. 03 ] Available from: https://doi.org/10.21037/atm.2020.02.23
Artigo de periodico
High-content screen in human pluripotent cells identifies miRNA-regulated pathways controlling pluripotency and differentiation (2019)
Lima, Ildercílio Mota de Souza ; Schiavinato, Josiane Lilian dos Santos; Leite, Sarah Blima Paulino; Sastre, Danuta; Bezerra, Hudson Lenormando de Oliveira; Sangiorgi, Bruno Braga; Corveloni, Amanda Cristina; Thomé, Carolina Hassibe ; Faça, Vitor Marcel ; Covas, Dimas Tadeu ; Zago, Marco Antonio; Giacca, Mauro; Mano, Miguel; Panepucci, Rodrigo Alexandre
Source: Stem Cell Research & Therapy. Unidade: FMRP
Subjects: CÉLULAS-TRONCO, MICRORNAS, DIFERENCIAÇÃO CELULAR, RECEPTORES, MICROSCOPIA, FLUORESCÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Ildercílio Mota de Souza et al. High-content screen in human pluripotent cells identifies miRNA-regulated pathways controlling pluripotency and differentiation. Stem Cell Research & Therapy, v. 10, 2019Tradução . . Disponível em: https://doi.org/10.1186/s13287-019-1318-6. Acesso em: 03 nov. 2024.
APA
Lima, I. M. de S., Schiavinato, J. L. dos S., Leite, S. B. P., Sastre, D., Bezerra, H. L. de O., Sangiorgi, B. B., et al. (2019). High-content screen in human pluripotent cells identifies miRNA-regulated pathways controlling pluripotency and differentiation. Stem Cell Research & Therapy, 10. doi:10.1186/s13287-019-1318-6
NLM
Lima IM de S, Schiavinato JL dos S, Leite SBP, Sastre D, Bezerra HL de O, Sangiorgi BB, Corveloni AC, Thomé CH, Faça VM, Covas DT, Zago MA, Giacca M, Mano M, Panepucci RA. High-content screen in human pluripotent cells identifies miRNA-regulated pathways controlling pluripotency and differentiation [Internet]. Stem Cell Research & Therapy. 2019 ; 10[citado 2024 nov. 03 ] Available from: https://doi.org/10.1186/s13287-019-1318-6
Vancouver
Lima IM de S, Schiavinato JL dos S, Leite SBP, Sastre D, Bezerra HL de O, Sangiorgi BB, Corveloni AC, Thomé CH, Faça VM, Covas DT, Zago MA, Giacca M, Mano M, Panepucci RA. High-content screen in human pluripotent cells identifies miRNA-regulated pathways controlling pluripotency and differentiation [Internet]. Stem Cell Research & Therapy. 2019 ; 10[citado 2024 nov. 03 ] Available from: https://doi.org/10.1186/s13287-019-1318-6
Artigo de periodico
Anti-complement treatment for paroxysmal nocturnal hemoglobinuria: time for proximal complement inhibition? A position paper from the SAAWP of the EBMT (2019)
Risitano, Antonio M.; Marotta, Serena; Ricci, Patrizia; Marano, Luana; Frieri, Camilla; Cacace, Fabiana; Sica, Michela; Kulasekararaj, Austin G.; Calado, Rodrigo Tocantins ; Scheinberg, Phillip; Notaro, Rosario; Latour, Régis Peffault de
Source: Frontiers in Immunology. Unidade: FMRP
Subjects: HEMOGLOBINAS, HEMATOLOGIA, ANEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RISITANO, Antonio M. et al. Anti-complement treatment for paroxysmal nocturnal hemoglobinuria: time for proximal complement inhibition? A position paper from the SAAWP of the EBMT. Frontiers in Immunology, v. 10, 2019Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2019.01157. Acesso em: 03 nov. 2024.
APA
Risitano, A. M., Marotta, S., Ricci, P., Marano, L., Frieri, C., Cacace, F., et al. (2019). Anti-complement treatment for paroxysmal nocturnal hemoglobinuria: time for proximal complement inhibition? A position paper from the SAAWP of the EBMT. Frontiers in Immunology, 10. doi:10.3389/fimmu.2019.01157
NLM
Risitano AM, Marotta S, Ricci P, Marano L, Frieri C, Cacace F, Sica M, Kulasekararaj AG, Calado RT, Scheinberg P, Notaro R, Latour RP de. Anti-complement treatment for paroxysmal nocturnal hemoglobinuria: time for proximal complement inhibition? A position paper from the SAAWP of the EBMT [Internet]. Frontiers in Immunology. 2019 ; 10[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fimmu.2019.01157
Vancouver
Risitano AM, Marotta S, Ricci P, Marano L, Frieri C, Cacace F, Sica M, Kulasekararaj AG, Calado RT, Scheinberg P, Notaro R, Latour RP de. Anti-complement treatment for paroxysmal nocturnal hemoglobinuria: time for proximal complement inhibition? A position paper from the SAAWP of the EBMT [Internet]. Frontiers in Immunology. 2019 ; 10[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fimmu.2019.01157

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration